Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Oveporexton for Narcolepsy Type 1 - Results from Two Phase 3 Trials.

Over a period of 12 weeks, oveporexton significantly improved measures of wakefulness, sleepiness, and cataplexy in participants with narcolepsy type 1.

Y. Dauvilliers, Emmanuel Mignot, J. Antczak et al. · 3 citations · ⚡2

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.